Johnson & Johnson | chemanager-online.com - Chemistry and Life Science

Jan. 13, 2020
News & Opinions
New Study Relativizes Talc-Cancer Ties
A new study published in the Journal of the American Medical Association (JAMA), which found “no statistically significant association” between genital talc use and ovarian cancer, could aid Johnson & Johnson in dealing ...
Jan. 06, 2020
News & Opinions
J&J Wins one Lawsuit, New Cases Loom
US healthcare giant Johnson & Johnson has been on a roller coaster ride for around two years, and its fortunes – along with its share price – continued moving up and down as 2019 gave way to 2020.
Nov. 21, 2019
News & Opinions
Oklahoma Cuts J&J Opioid Fine by $107 Million
Oklahoma judge Thad Balkman has reduced the fine levied on Johnson & Johnson in a landmark opioid case concluded in August by $107 million, from $57 2million to $465 million. The reduction takes account of the court’s ...
Oct. 22, 2019
News & Opinions
Ohio Settles with Four US Opioid Players
After negotiating through the night, Israeli generics giant Teva – which is a leading supplier of the US market – and the three biggest US drug distributors on Oct. 21 reached a $260 million settlement with two Ohio counties ...
Oct. 21, 2019
News & Opinions
FDA Finds Asbestos in J&J Baby Powder
Johnson & Johnson (J&J) has voluntarily recalled 33,000 bottles of its iconic baby powder in the US, after the Food and Drug Administration (FDA) found traces of asbestos in one batch. ...
Oct. 17, 2019
News & Opinions
US Opioid Settlement Talks in High Gear
Long anticipated bundled proceedings against opioid manufacturers and US opioid distributors began on Oct. 16 in a US court in Cleveland, Ohio, where cases against Israeli generics giant Teva and five distributors were to be heard. ...
Oct. 10, 2019
News & Opinions
J&J Ordered to Pay $8 Billion in Risperdal Case
A jury in Philadelphia, Pennsylvania, has ordered US healthcare giant Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a man who claims the company’s anti-psychotic drug Risperdal caused him to grow breasts.
Sep. 03, 2019
News & Opinions
Opioid Makers Angling to Settle out of Court
After Johnson & Johnson last week was ordered to pay $572 million to the state of Oklahoma, analysts and other observers said the verdict could prompt other opioid makers to think more seriously about settling.
Jul. 19, 2019
News & Opinions
J&J Said Facing Criminal Probe on Talc
Still facing thousands of lawsuits claiming that its talc products caused the plaintiffs’ cancer, US healthcare giant Johnson & Johnson (J&J) has won some smaller cases and lost bigger ones – which it is appealing. ...
Feb. 06, 2019
News & Opinions
Janssen and MeiraGTx Link on Optical Gene Therapy
Janssen, the pharmaceuticals arm of Johnson & Johnson, is once again collaborating with US clinical-stage gene therapy company MeiraGTx to develop and commercialize treatments for inherited retinal diseases (IRDs).

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag